Related Experiment Video
Updated: Jun 4, 2025

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
Published on: March 1, 2024
CNPY2 modulates senescence-associated secretory phenotype in tendon stem/progenitor cells
1Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China; Department of Orthopaedics, The Eighth People's Hospital of Tongzhou, Nantong, Jiangsu, China.
Aging causes tendon stem cell senescence and inflammation via the senescence-associated secretory phenotype (SASP). Reduced Canopy homolog 2 (CNPY2) drives this process, suggesting CNPY2 as a target for age-related tendon disorders.
Area of Science:
- Cellular Biology
- Aging Research
- Biochemistry
Background:
- Chronic inflammation is linked to age-related diseases.
- Senescent cells release inflammatory factors, known as the senescence-associated secretory phenotype (SASP).
- Tendon aging involves the accumulation of senescent tendon stem/progenitor cells (TSPCs) and SASP development.
Purpose of the Study:
- To investigate the role of Canopy homolog 2 (CNPY2) in TSPCs senescence and SASP.
- To explore the mechanism by which CNPY2 influences TSPCs SASP.
- To identify potential therapeutic targets for age-related tendon disorders.
Main Methods:
- Induction of cellular inflammation in young TSPCs using conditioned medium from aged TSPCs.
- Analysis of CNPY2 expression in aging tendon tissue.
- Investigation of CNPY2 deficiency effects on TSPCs senescence and SASP.
- Assessment of NF-κB signaling pathway activation in CNPY2 knockdown TSPCs.
- Pharmacological inhibition of NF-κB signaling using BMS-345541 to evaluate SASP attenuation.
Main Results:
- Aging leads to senescent TSPCs accumulation and SASP development in tendons.
- CNPY2 expression decreases during tendon aging.
- CNPY2 deficiency induces TSPCs senescence and SASP.
- NF-κB signaling pathway is activated in CNPY2-deficient TSPCs.
- Inhibition of NF-κB signaling reduces SASP in senescent TSPCs.
Conclusions:
- CNPY2 plays a critical role in regulating TSPCs senescence and SASP.
- CNPY2 appears to modulate TSPCs SASP through the NF-κB signaling pathway.
- CNPY2 represents a potential therapeutic target for age-related tendon disorders.
More Related Videos
Related Concept Videos
Stem Cell Niche
Satellite Stem Cells and Muscular Dystrophy
Replicative Cell Senescence
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

